This Virtual Roundtable Discussion Summary is available only to Global Business Services members. For information on membership, please contact us

Life sciences GCCs in India are becoming essential innovation and technology development hubs, moving toward complex, value-driven processes across the life sciences value chain. For sustained growth, GCCs need to address key challenges: shifting from a service-oriented mindset to a collaborative, business-driven approach and being viewed not as support functions but as core business units. Fostering a culture that sees third-party providers as collaborators rather than competitors is equally important.

Generative AI presents significant potential for GCCs, but its adoption must be cautious. Ensuring regulatory compliance, assessing data readiness, and aligning innovation with organizational goals are essential. By adopting a step-by-step approach to generative AI implementation and upskilling employees, GCCs can sustainably unlock their value while staying aligned with enterprise objectives.

Scope

• Industry: life sciences
• Geography: global

Contents

Our discussion focuses on:

• The evolving role of life sciences GCCs in driving technology transformations
• Technology ownership in GCCs across the life sciences value chain
• Investment strategies for emerging technologies and approaches to quantify value
• Optimizing operating structures to help GCC teams enable technology transformations